| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.6M | +65.3% |
| Cost of Revenue | $8.9M | +63.8% |
| Gross Profit | -$3.3M | -61.4% |
| R&D Expense | $8.4M | +50.8% |
| SG&A Expense | $11.7M | +139.8% |
| Operating Income | -$32.0M | -30.2% |
| Pre-tax Income | -$25.6M | +41.5% |
| Net Income | -$25.6M | +41.5% |
| EPS (Basic) | -$0.72 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.8M | -55.3% |
| Accounts Receivable | $1.4M | +15.2% |
| Inventory | $2.6M | — |
| Current Assets | $10.1M | -24.4% |
| Total Assets | $22.1M | +25.6% |
| Current Liabilities | $10.5M | -14.2% |
| Long-term Debt | $8.7M | +22.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.1M | -19.7% |
| Capital Expenditures | $111K | -5.1% |
| Investing Cash Flow | -$9.9M | -325.7% |
| Financing Cash Flow | $28.0M | +7.0% |
| Free Cash Flow | -$24.2M | -19.5% |
| +82.8% |
| EPS (Diluted) | -$0.72 | +82.8% |
| Total Liabilities |
| $29.9M |
| -31.0% |
| Stockholders' Equity | -$43.6M | +47.4% |